Cargando…
FGF21 gene therapy as treatment for obesity and insulin resistance
Prevalence of type 2 diabetes (T2D) and obesity is increasing worldwide. Currently available therapies are not suited for all patients in the heterogeneous obese/T2D population, hence the need for novel treatments. Fibroblast growth factor 21 (FGF21) is considered a promising therapeutic agent for T...
Autores principales: | Jimenez, Veronica, Jambrina, Claudia, Casana, Estefania, Sacristan, Victor, Muñoz, Sergio, Darriba, Sara, Rodó, Jordi, Mallol, Cristina, Garcia, Miquel, León, Xavier, Marcó, Sara, Ribera, Albert, Elias, Ivet, Casellas, Alba, Grass, Ignasi, Elias, Gemma, Ferré, Tura, Motas, Sandra, Franckhauser, Sylvie, Mulero, Francisca, Navarro, Marc, Haurigot, Virginia, Ruberte, Jesus, Bosch, Fatima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6079533/ https://www.ncbi.nlm.nih.gov/pubmed/29987000 http://dx.doi.org/10.15252/emmm.201708791 |
Ejemplares similares
-
AAV-mediated BMP7 gene therapy counteracts insulin resistance and obesity
por: Casana, Estefania, et al.
Publicado: (2022) -
In Vivo Adeno-Associated Viral Vector–Mediated Genetic Engineering of White and Brown Adipose Tissue in Adult Mice
por: Jimenez, Veronica, et al.
Publicado: (2013) -
Integrated gene expression profiles reveal a transcriptomic network underlying the thermogenic response in adipose tissue
por: Rodó, Jordi, et al.
Publicado: (2023) -
Vitamin D Receptor Overexpression in β-Cells Ameliorates Diabetes in Mice
por: Morró, Meritxell, et al.
Publicado: (2020) -
AAV-mediated pancreatic overexpression of Igf1 counteracts progression to autoimmune diabetes in mice
por: Mallol, Cristina, et al.
Publicado: (2017)